Advantix 40 mg + 200 mg spot-on solution for dogs (≤ 4 kg)// Advantix 100 mg + 500 mg spot-on solution for dogs (> 4 kg ≤ 10 kg)/Advantix 250 mg + 1250 mg spot-on solution for dogs (> 10 kg ≤ 25 kg)/Advantix 400 mg + 2000 mg spot-on solution for dogs (> 25 kg ≤ 40 kg)/Advantix 600 mg + 3000 mg spot-on solution for dogs (> 40 kg ≤ 60 kg)
Advantix 40 mg + 200 mg spot-on solution for dogs (≤ 4 kg)// Advantix 100 mg + 500 mg spot-on solution for dogs (> 4 kg ≤ 10 kg)/Advantix 250 mg + 1250 mg spot-on solution for dogs (> 10 kg ≤ 25 kg)/Advantix 400 mg + 2000 mg spot-on solution for dogs (> 25 kg ≤ 40 kg)/Advantix 600 mg + 3000 mg spot-on solution for dogs (> 40 kg ≤ 60 kg)
Authorised
- Permethrin
- Imidacloprid
Product identification
Medicine name:
Advantix 40 mg + 200 mg spot-on solution for dogs (≤ 4 kg)// Advantix 100 mg + 500 mg spot-on solution for dogs (> 4 kg ≤ 10 kg)/Advantix 250 mg + 1250 mg spot-on solution for dogs (> 10 kg ≤ 25 kg)/Advantix 400 mg + 2000 mg spot-on solution for dogs (> 25 kg ≤ 40 kg)/Advantix 600 mg + 3000 mg spot-on solution for dogs (> 40 kg ≤ 60 kg)
Active substance:
- Permethrin
- Imidacloprid
Target species:
-
Dog
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Permethrin500.00/milligram(s)1.00millilitre(s)
-
Imidacloprid100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC54
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Available in:
-
Bulgaria
Package description:
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
- Available only in Bulgarian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2530
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/10/2025
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/10/2025
Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 6/10/2025